<?xml version="1.0" encoding="UTF-8"?>
<app-group>
 <app id="app1-antibiotics-09-00913">
  <title>Supplementary Materials</title>
  <p>The following are available online at 
   <uri xlink:href="https://www.mdpi.com/2079-6382/9/12/913/s1" xmlns:xlink="http://www.w3.org/1999/xlink">https://www.mdpi.com/2079-6382/9/12/913/s1</uri>, Figure S1: 
   <sup>1</sup>H NMR spectrum of 
   <bold>1</bold> in CDCl
   <sub>3</sub> (500 MHz); Figure S2: 
   <sup>1</sup>H NMR spectrum of 
   <bold>1</bold> (expanded) in CDCl
   <sub>3</sub> (500 MHz); Figure S3: 
   <sup>1</sup>H NMR spectrum of 
   <bold>1</bold> (expanded) in CDCl
   <sub>3</sub> (500 MHz); Figure S4: 
   <sup>13</sup>C NMR spectrum of 
   <bold>1</bold> in CDCl
   <sub>3</sub> (500 MHz); Figure S5: Expansion of HMQC spectrum of 
   <bold>1</bold> in CDCl
   <sub>3</sub>; Figure S6: Expansion of HMBC spectrum of 
   <bold>1</bold> in CDCl
   <sub>3</sub>; Figure S7: Expansion of COSY spectrum of 
   <bold>1</bold> in CDCl
   <sub>3</sub>; Figure S8: ESI-MS spectrum of 
   <bold>1</bold> showing peak ion at m/z 238.1 [M-H]
   <sup>-</sup> (indicated by arrow); Figure S9: 
   <sup>1</sup>H NMR spectrum of 
   <bold>2</bold> in CDCl
   <sub>3</sub> (500 MHz); Figure S10: 
   <sup>1</sup>H NMR spectrum of 
   <bold>2</bold> in CDCl
   <sub>3</sub> (500 MHz); Figure S11: 
   <sup>1</sup>H NMR spectrum of 
   <bold>2</bold> in CDCl
   <sub>3</sub> (500 MHz); Figure S12: 
   <sup>13</sup>CNMR spectrum of 
   <bold>2</bold> in CDCl
   <sub>3</sub> (125 MHz); Figure S13: HMQC spectrum of 
   <bold>2</bold> in CDCl
   <sub>3</sub>; Figure S14: HMBC spectrum of 
   <bold>2</bold> in CDCl
   <sub>3</sub>; Figure S15: COSY spectrum of 
   <bold>2</bold> in CDCl
   <sub>3</sub>; Figure S16: HRMS spectrum of 
   <bold>2</bold> showing peak ion at m/z 255.0627; Figure S17: 
   <sup>1</sup>H NMR spectrum of 
   <bold>3</bold> in CDCl
   <sub>3</sub> (500 MHz); Figure S18: 
   <sup>13</sup>C spectrum of 
   <bold>3</bold> in CDCl
   <sub>3</sub> (125 MHz); Figure S19: 
   <sup>13</sup>C spectrum of 
   <bold>3</bold> in CDCl
   <sub>3</sub> (125 MHz); Figure S20: HMQC spectrum of 
   <bold>3</bold> in CDCl
   <sub>3</sub>; Figure S21: HMBC spectrum of 
   <bold>3</bold> in CDCl
   <sub>3</sub>; Figure S22: COSY spectrum of 
   <bold>3</bold> in CDCl
   <sub>3</sub>; Figure S23: ESI-MS spectrum of 
   <bold>3</bold> showing peak ion at m/z 166.0 (indicated by arrow); Figure S24: 
   <sup>1</sup>H NMR spectrum of 
   <bold>4</bold> in CDCl
   <sub>3</sub> (500 MHz); Figure S25: 
   <sup>13</sup>C NMR spectrum of 
   <bold>4</bold> in CDCl
   <sub>3</sub> (125 MHz); Figure S26: 
   <sup>13</sup>C NMR spectrum of 
   <bold>4</bold> (expanded) in CDCl
   <sub>3</sub> (125 MHz); Figure S27: HMQC spectrum of 
   <bold>4</bold> in CDCl
   <sub>3</sub>; Figure S28: HMBC spectrum of 
   <bold>4</bold> in CDCl
   <sub>3</sub>; Figure S29: COSY spectrum of 
   <bold>4</bold> in CDCl
   <sub>3</sub>; Figure S30: HRMS spectrum of 
   <bold>4</bold> showing peak ion at m/z 373.2732; Figure S31: The EI mass spectrum of the GC peak corresponding to the alkenyl chain of 4 as identified from the NIST database (fragmentation pattern proposed as oleic acid trimethylsilyl acid); Figure S32: Preparation of dimethyl disulphide derivatives; Figure S33: Derivatisation of the hydroxyl groups; Table S1: 
   <sup>1</sup>H (500 MHz) and 
   <sup>13</sup>C NMR (125 MHz) and HMBC spectroscopic data of 
   <bold>1</bold> recorded in CDCl
   <sub>3</sub> compared with published data; Table S2: Comparison of the hydrogen chemical shifts and coupling constants between 
   <bold>2</bold> with 3 other known styryllactones; Table S3: 
   <sup>1</sup>H (500 MHz) and 
   <sup>13</sup>C NMR (125 MHz) and HMBC spectroscopic data of 2 recorded in CDCl3; Table S4:. 
   <sup>1</sup>H (500 MHz),
   <sup>13</sup>C NMR (125 MHz) and HMBC spectroscopic data of 
   <bold>3</bold> and 
   <bold>4</bold> recorded in CDCl3.
  </p>
 </app>
</app-group>
